Literature DB >> 33511517

α-Tocopherol Acetate Attenuates Mitochondrial Oxygen Consumption and Maintains Primitive Cells within Mesenchymal Stromal Cell Population.

Darija Loncaric1,2,3, Laura Rodriguez1,2,3, Christelle Debeissat1,2,3, Nicolas Touya1,2,3, Veronique Labat1,2,3, Arnaud Villacreces2,3, Anne-Karine Bouzier-Sore4, Jean-Max Pasquet2,3, Philippe Brunet de la Grange1,2,3, Marija Vlaski-Lafarge1,2,3, Sonja Pavlovic5, Zoran Ivanovic6,7.   

Abstract

We present here the data showing, in standard cultures exposed to atmospheric O2 concentration, that alpha-tocopherol acetate (α-TOA) has a positive impact on primitive cells inside mesenchymal stromal cell (MstroC) population, by maintaining their proliferative capacity. α-TOA decreases the O2 consumption rate of MStroC probably by impacting respiratory chain complex II activity. This action, however, is not associated with a compensatory increase in glycolysis activity, in spite of the fact that the degradation of HIF-1α was decreased in presence of α-TOA. This is in line with a moderate enhancement of mtROS upon α-TOA treatment. However, the absence of glycolysis stimulation implies the inactivity of HIF-1α which might - if it were active - be related to the maintenance of stemness. It should be stressed that α-TOA might act directly on the gene expression as well as the mtROS themselves, which remains to be elucidated. Alpha-tocopherol acetate (α-TOA), a synthetic vitamin E ester, attenuates electron flow through electron transport chain (ETC) which is probably associated with a moderate increase in mtROS in Mesenchymal Stromal Cells. α-TOA action results in enhancement of the proliferative capacity and maintenance of the differentiation potential of the mesenchymal stem and progenitor cells.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC part of Springer Nature.

Entities:  

Keywords:  Alpha-tocopherol acetate; Electron transport chain; HIF-1α; MPC; MSC; MStroC; mtROS

Mesh:

Substances:

Year:  2021        PMID: 33511517     DOI: 10.1007/s12015-020-10111-9

Source DB:  PubMed          Journal:  Stem Cell Rev Rep        ISSN: 2629-3277            Impact factor:   6.692


  41 in total

1.  Factors influencing blood concentration of retinol, alpha-tocopherol, vitamin C, and beta-carotene in the French participants of the SU.VI.MAX trial.

Authors:  H Faure; P Preziosi; A-M Roussel; S Bertrais; P Galan; S Hercberg; A Favier
Journal:  Eur J Clin Nutr       Date:  2006-01-04       Impact factor: 4.016

2.  Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement.

Authors:  M Dominici; K Le Blanc; I Mueller; I Slaper-Cortenbach; Fc Marini; Ds Krause; Rj Deans; A Keating; Dj Prockop; Em Horwitz
Journal:  Cytotherapy       Date:  2006       Impact factor: 5.414

3.  Respect the anaerobic nature of stem cells to exploit their potential in regenerative medicine.

Authors:  Zoran Ivanovic
Journal:  Regen Med       Date:  2013-11       Impact factor: 3.806

4.  Hypoxic preconditioning of mesenchymal stromal cells induces metabolic changes, enhances survival, and promotes cell retention in vivo.

Authors:  Julie Beegle; Kinga Lakatos; Stefanos Kalomoiris; Heather Stewart; R Rivkah Isseroff; Jan A Nolta; Fernando A Fierro
Journal:  Stem Cells       Date:  2015-05-11       Impact factor: 6.277

Review 5.  Stem cell evolutionary paradigm and cell engineering.

Authors:  Z Ivanovic
Journal:  Transfus Clin Biol       Date:  2017-06-05       Impact factor: 1.406

6.  The majority of cells in so-called "mesenchymal stem cell" population are neither stem cells nor progenitors.

Authors:  D Loncaric; V Labat; C Debeissat; P Brunet de la Grange; L Rodriguez; M Vlaski-Lafarge; Z Ivanovic
Journal:  Transfus Clin Biol       Date:  2018-08-25       Impact factor: 1.406

Review 7.  Strategies to Enhance Implantation and Survival of Stem Cells After Their Injection in Ischemic Neural Tissue.

Authors:  Ioanna Sandvig; Ivana Gadjanski; Marija Vlaski-Lafarge; Leonora Buzanska; Darija Loncaric; Ana Sarnowska; Laura Rodriguez; Axel Sandvig; Zoran Ivanovic
Journal:  Stem Cells Dev       Date:  2017-01-18       Impact factor: 3.272

8.  Mesenchymal stromal cells for cardiovascular disease.

Authors:  Ian B Copland
Journal:  J Cardiovasc Dis Res       Date:  2011-01

Review 9.  How to Improve the Survival of Transplanted Mesenchymal Stem Cell in Ischemic Heart?

Authors:  Liangpeng Li; Xiongwen Chen; Wei Eric Wang; Chunyu Zeng
Journal:  Stem Cells Int       Date:  2015-11-22       Impact factor: 5.443

10.  Mesenchymal Stem Cells: Time to Change the Name!

Authors:  Arnold I Caplan
Journal:  Stem Cells Transl Med       Date:  2017-04-28       Impact factor: 6.940

View more
  1 in total

1.  α-Tocopherol Attenuates Oxidative Phosphorylation of CD34+ Cells, Enhances Their G0 Phase Fraction and Promotes Hematopoietic Stem and Primitive Progenitor Cell Maintenance.

Authors:  Laura Rodriguez; Pascale Duchez; Nicolas Touya; Christelle Debeissat; Amélie V Guitart; Jean-Max Pasquet; Marija Vlaski-Lafarge; Philippe Brunet de la Grange; Zoran Ivanovic
Journal:  Biomolecules       Date:  2021-04-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.